Risk of meningococcal infection in college students

JAMA

Volumn 281, Issue 20, 1999, Pages 1906-1910

  Harrison, Lee H ^a,b   Dwyer, Diane M ^d   Maples, Charles T ^a,c   Billmann, Lillian ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d 521 Parran Hall ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; COLLEGE STUDENT; FEMALE; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0033606236     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.20.1906     Document Type: Article

References (23)

1. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States In 1995: Active Surveillance Team. N Engl J Med. 1997;337:970-976.
2. Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States: an emerging threat. JAMA. 1995;273:383-389.
3. Woods CW, Rosenstein N, Perkins BA. Neisseria meningitidis outbreaks in the United States, 1994-97. In: Program and abstracts of the 36th Annual Meeting of the Infectious Diseases Society of America; November 12-15, 1998; Denver, Colo. Abstract 125.
4. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46:13-21.
5. American College Health Association. Recommendation on meningococcal meningitis vaccination. Available at: http://www.acha.org/resource-info/ meningitis-faq.htm. Accessed April 14, 1999.
6. Jackson LA, Schuchat A, Gorsky RD, Wenger JD. Should college students be vaccinated against meningococcal disease? a cost-benefit analysis. Am J Public Health. 1995;85:843-845.
7. Brundage JF, Zollinger WD. Evolution of meningococcal disease in the U.S. Army. In: Vedros NA, ed. Evolution of Meningococca/Disease. Boca Raton, Fla: CRC Press; 1987:5-25.
8. Harrison LH, Elliott JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J Infect Dis, 1998;177:998-1002.
9. Fischer M, Harrison L, Farley M, et al. Risk factors for sporadic meningococcal disease in North America. In: Program and abstracts of the 36th Annual Meeting of the Infectious Diseases Society of America; November 12-15, 1998; Denver, Colo. Abstract 552.
10. Nguyen-Van-Tam JS, Neal KR, Monk P, O'Brien SJ, Stuart J, Ramsay M. Invasive meningococcal disease among university undergraduates: association with catered halls of residence. Paper presented at: 11th International Pathogenic Neisseria Conference; November 1-6, 1998; Nice, France.
11. Froeschle JE. Meningococcal disease in college students [letter]. Clin Infect Dis. In press.
12. Imrey PB, Jackson LA, Ludwinski PH, et al. Meningococcal carriage, alcohol consumption, and campus bar patronage in a serogroup C meningococcal disease outbreak. J Clin Microbiol. 1995;33:3133-3137.
13. Imrey PB, Jackson LA, Ludwinski PH, et al. Outbreak of serogroup C meningococcal disease associated with campus bar patronage. Am J Epidemiol. 1996;143:624-630.
14. Fischer M, Hedberg K, Cardosi P, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J. 1997;16:979-983.
15. Jackson LA, Wenger JD. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991. MMWR CDC Surveill Summ. 1993;42(2):21-30.
16. Moore PS. Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. Clin Infect Dis. 1992;14:515-525.
17. Harrison LH. The worldwide prevention of meningococcal infection: still an elusive goal [editorial]. JAMA. 1995;273:419-421.
18. Rosenstein N, Levine O, Taylor JP, et al. Efficacy of meningococcal vaccine and barriers to vaccination. JAMA. 1998;279:435-439.
19. Broome CV. The carrier state: Neisseria meningitidis. J Antimicrob Chemother. 1986;18(suppl A): 25-34.
20. Harrison LH, Broome CV. The epidemiology of meningococcal meningitis in the U.S. civilian population. In: Vedros NA, ed. Evolution of Meningococcal Disease. Boca Raton, Fla: CRC Press; 1987: 27-45.
21. Serogroup Y meningococcal disease - Illinois, Connecticut, and selected areas, United States, 1989-1996. MMWR Morb Mortal Wkly Rep. 1996;45: 1010-1013.
22. Roberts CL, Roome A, Algert CS, et al. A meningococcal vaccination campaign on a university campus: vaccination rates and factors in nonparticipation. Am J Public Health. 1996;86:1155-1158.
23. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46:1-10.